Who Paid My Doc Search
Menu
Organisation paid for research Program year 2022 Source: CMS Open Payments

ClinVax Clinical Trial

Neither a doctor nor a teaching hospital

Research payments

$78,004

4 payments

Through program year 2022, ClinVax Clinical Trial is reported as receiving $78,004 in research payments, across 4 payments.

By program year

3 rows
Year Kind Amount Payments
2022 Research $297 1
2021 Research $50,825 2
2020 Research $26,882 1

Breakdown

Who paid Research payments · program years 2020–2022
  1. Boehringer Ingelheim Pharmaceuticals, Inc. $78,004 4 payments
Studies the money was for Research payments · program years 2020–2022
  1. Flare Prevention Phase IIb Trial in GPP $65,004 3 payments
  2. 5 Years OLE Phase III Trial in GPP $13,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record